Biopolym. Cell. 2013; 29(6):463-467.
http://dx.doi.org/10.7124/bc.00083A
Structure and Function of Biopolymers
Impact of siRNA transfection on tumor development under experimental pathology of thyroid gland
1Zaporozhan V. M., 1Maryniuk G. S., 1Kholodkova O. L., 1Bubnov V. V., 1Andronov D. U.
  1. Odessa National Medical University
    2, Valikhovskiy lane, 2.Odessa, Ukraine, 65082

Abstract

Aim. To assess the impact of siRNA transfection on the tumor development under experimental pathology of the thyroid gland. Methods. Experiments were performed on rats weighing 180 ± 20 g, which were divided into five groups: IA and IB – animals with simulated hypo- and hyperthyroid states and transplanted Guerin’s carcinoma; IIA and IIB – animals with simulated hypo- and hyperthyroid states and transplanted Guerin’s carcinoma in combination with siRNA transfection; III – control group with transplanted Guerin’s carcinoma in combination with siRNA transfection. Orthogonal dimensions of the tumor were measured. Histological and immunohistochemical researches of tumor samples were performed. Results. It has been shown that the inhibitory effect of short interfering RNA is realized to a greater extent in the hypothyroid state, indicating an important role of thyroid hormones in the regulation of expression of genes that control the cell cycle. We discuss a possible dependence of necrobiotic processes prevalence and characteristic changes in the blood vessels on the effects of thyroid hormones on angiogenesis and proliferative processes. Conclusions. siRNA trasfection leads to inhibition of tumor growth in animals with both hypo- and hyperthyroidism, but it is more pronounced at hypothyroidism.
Keywords: transfection, siRNA, experimental model, hypothyroidism, hyperthyroidism
Full text: (PDF, in English)

References

[1] Brent G. A. Mechanisms of thyroid hormone action J. Clin. Invest 2012 122, N 9:3035–3043.
[2] Sar P., Peter R., Rath B. Das Mohapatra A., Mishra S. K. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements PLoS One 2011 6, N 6 e20861.
[3] Khatri N., Rathi M., Baradia D., Trehan S., Misra A. In vivo delivery aspects of miRNA, shRNA and siRNA Crit. Rev. Ther. Drug. Carrier. Syst 2012 29, N 6:487–527.
[4] Zhou J., Bobbin M. L., Burnett J. C., Rossi J. J. Current progress of RNA aptamer-based therapeutics Front. Genet 2012 3:234.
[5] Chaturvedi K., Ganguly K., Kulkarni A. R., Kulkarni V. H., Nadagouda M. N., Rudzinski W. E., Aminabhavi T. M. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review Expert. Opin. Drug. Deliv 2011 8, N 11:1455–1468.
[6] McNaughton B. R., Cronican J. J., Thompson D. B., Liu D. R. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins Proc. Natl Acad. Sci. USA 2009 106, N 15:6111–6116.
[7] Baudarbekova M. M. Ki-67 that PCNA expression in hyperplastic states and adenocarcinoma of the endometrium in women of perimenopauzal condition Oncology 2010 12, N 4:394.
[8] Zak M. U. Cell renewal in the gastric mucosa in patients with chronic atrophic gastritis Contemporary Gastroenterology 2011 2, N 58 P. 27–32.
[9] Borovikov O. P. STATISTICA: the art of analyzing data on a computer (2nd ed.) Moscow: Science, 2007 700 p
[10] Chen C. L., Hsieh F. C., Lieblein J. C. Brown J., Chan C., Wallace J. A., Cheng G., Hall B. M., Lin J. Stat3 activation in human endometrial and cervical cancers Br. J. Cancer 2007 96, N 4:591–599.
[11] Liu J., Xu X., Feng X., Zhang B., Wang J. Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251 J. Exp. Clin. Cancer Res 2011 30 p 80.
[12] Calabrese V., Mallette F. A., Deschenes-Simard X., Ramanathan S., Gagnon J., Moores A., Ilangumaran S., Ferbeyre G. SOCS1 links cytokine signaling to p53 and senescence Mol. Cell 2009 36, N 5:754–767.
[13] Miele E., Spinelli G. P., Miele E., Di Fabrizio E., Ferretti E., Tomao S., Gulino A. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy Int. J. Nanomedcine 2012 7:3637–3657.
[14] Ni Y. H., Wang Z. Y., Huang X. F., Shi P. H., Han W., Hou Y. Y., Hua Z. C., Hu A. Q. Effect of siRNA-mediated downregulation of VEGF in Tca8113 cells on the activity of monocyte-derived dendritic cells Oncol. Lett 2012 3, N 4:885–892.
[15] Gnocchi D., Leoni S., Incerpi S., Bruscalupi G. 3,5,3'-triiodothyronine (T3) stimulates cell proliferation through the activation of the PI3K/Akt pathway and reactive oxygen species (ROS) production in chick embryo hepatocytes Steroids 2012 77, N 6:589–595.
[16] Kim J. H., Kang T. H., Noh K. H., Bae H. C., Ahn Y. H., Lee Y. H., Choi E. Y., Chun K. H., Lee S. J., Kim T. W. Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency Clin. Exp. Immunol. 2011 165, N 2:180–189.